Semax Coupon: Half Off a Batch That Has a Report Number

The Semax coupon attached to the offer below is PEPTIDEDECK, and on a single 10 mg vial it takes $59.99 to $30.00, or $3.00 per labelled milligram. That is the entire commercial story and it occupies one line of arithmetic.

What makes the page worth writing is that this order carries a second number you can check rather than trust. The discount is confirmed in the cart before you pay. The batch identifier is confirmed against the vial after it arrives, and it is the one that decides whether the analytical document you were shown describes the material in your hand.

The offer these figures come from:

What the Semax coupon changes in the order summary

One presentation is sold, a 10 mg lyophilised vial, so there is no size arbitrage to work out. The code halves a single-vial order and the separate quantity tiers apply to the list price.

The gap between the top row and the rest is the point. Ten vials at the deepest tier still cost $5.40 per labelled milligram, while one vial with the code costs $3.00. Buying volume to chase a tier is the more expensive route to a cheaper milligram, and it also commits you to nine additional vials of a compound you may not want nine of.

A code either survives to the payment step or it does not, and the order summary is where that is settled. What you are looking for is a discount line carrying the code itself rather than a vaguely worded reduction, a subtotal that has moved by the amount you expected, and shipping and tax calculated after the reduction rather than before it. If the code is entered and the total does not change, it is not live for that basket, whatever any page claims about it, including this one. Codes expire, and an article can only ever report the offer as published on its review date.

Whether the code applies across a multi-vial basket, and whether it can be combined with a tier, is not addressed anywhere in the published terms. We are not going to guess at it. Enter the code on the basket you actually want and read the summary line by line before paying, which settles the question for your order in a way no article can. Free carriage begins at $250, a threshold five vials at tier pricing crosses and three do not. The equivalent arithmetic on the neighbouring compound, where the same code applies to a thinner analytical file, is in our reading of the Selank discount and its certificate.

The second number on this order that can be checked

The certificate published for this product covers batch 30-05260628 and carries report number KVR-2026-E848E0, issued by Kovera Labs and certified on 15 June 2026. Each report section in the four-page file prints its own access code alongside a verification address at koveralabs.com/verify. Whether or not you use that lookup, the presence of a report number, a named laboratory, a signatory and a dated analysis is what separates a document from a graphic.

The check that costs nothing is the batch match. Read the batch number on the label of the vial you were sent and compare it with the batch number at the top of the certificate you were shown before ordering. If they differ, the document is a statement about other material, and the correct response is to ask the seller for the certificate covering the batch you received rather than to assume the numbers carry over.

The reason this matters more here than on a typical listing is that the document is unusually complete. Batch 30-05260628 reports purity of 99.886 percent against a specification above 98 percent, identity confirmed by liquid chromatography with mass spectrometry, net content of 11.23 mg against an approximate 10 mg specification, bacterial endotoxin below 0.20 EU/mL against a 0.5 EU/mL limit by kinetic chromogenic LAL assay to USP Chapter 85 across a 2.0 mL dilution volume, so below 0.40 EU per vial, a rapid two-day sterility screen returning no growth that stops short of calling itself compendial, and lead, arsenic, cadmium and mercury each below their acceptance limits. A file that thorough is worth attaching to the right vial.

It is also worth knowing what the alternative looks like, and the comparison is available without leaving the same storefront. This vendor’s own February certificates, Semax lot 30-01260229 among them, run to two pages and carry no endotoxin assay, no sterility screen and no metals panel; its June batches, Selank 29-05260628 included, carry all three. Same seller, same code, similar price bracket, and a materially different amount of laboratory work depending on which batch is in the box. The premium on one product does not buy a wider panel than the other, because the panel moved across the catalogue in June rather than per product. Read every certificate shown on a product page rather than only the one that is a clickable link, and the point settles in under a minute.

What a working code cannot certify

A discount is a commercial setting applied to a listing. It says nothing about identity, nothing about purity, nothing about pyrogen load and nothing about the state of the peptide in the vial. Those are measurements, and a measurement is only as strong as the procedure behind it, which is the reasoning ICH Q2(R2) formalises for regulated analytical work. Research-supply certificates operate under no such obligation, so what carries weight is the specificity of the document: named methods, stated acceptance limits, instrument conditions and a batch identifier, rather than a percentage rendered in a large font. Our guide to grading the sources behind a peptide claim applies the same test to the literature a seller cites.

Nor does a code change the regulatory picture. This is a synthetic seven-residue peptide, PubChem CID 9811102, formula C37H51N9O10S, molecular weight 813.9, the ACTH(4-7) fragment extended with a Pro-Gly-Pro tail. It carries a Russian registration, which is a fact about a foreign regulatory system rather than evidence by Western standards, and the published mechanistic work is largely preclinical. FDA has granted it no marketing authorisation for any indication. Its nomination for the compounding bulks list was withdrawn by the nominator, so it sits in none of the three categories of the list updated on 14 May 2026, and the agency's published concern is immunogenicity arising from aggregation and peptide-related impurities in the absence of adequate human safety information.

Nothing on this page describes or implies human use, and there are no quantities here because quantity is not a discount question. For the framework this site applies to material sold under research-use terms, see what research-use supply actually means.